Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis
Publication
, Journal Article
Aseyev, O; Turek, M; Johnson, C; Crowley, F; Dent, S
Published in: Canadian Journal of Cardiology
April 1, 2016
Duke Scholars
Published In
Canadian Journal of Cardiology
DOI
ISSN
0828-282X
Publication Date
April 1, 2016
Volume
32
Issue
4
Start / End Page
S8
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Aseyev, O., Turek, M., Johnson, C., Crowley, F., & Dent, S. (2016). Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis. Canadian Journal of Cardiology, 32(4), S8. https://doi.org/10.1016/j.cjca.2016.02.023
Aseyev, O., M. Turek, C. Johnson, F. Crowley, and S. Dent. “Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis.” Canadian Journal of Cardiology 32, no. 4 (April 1, 2016): S8. https://doi.org/10.1016/j.cjca.2016.02.023.
Aseyev O, Turek M, Johnson C, Crowley F, Dent S. Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis. Canadian Journal of Cardiology. 2016 Apr 1;32(4):S8.
Aseyev, O., et al. “Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis.” Canadian Journal of Cardiology, vol. 32, no. 4, Apr. 2016, p. S8. Scopus, doi:10.1016/j.cjca.2016.02.023.
Aseyev O, Turek M, Johnson C, Crowley F, Dent S. Age is a Factor for Referral of Women With Left Ventricular Dysfunction During Trastuzumab-based Treatment for HER2-positive Breast Cancer: Single-center Retrospective Data Analysis. Canadian Journal of Cardiology. 2016 Apr 1;32(4):S8.
Published In
Canadian Journal of Cardiology
DOI
ISSN
0828-282X
Publication Date
April 1, 2016
Volume
32
Issue
4
Start / End Page
S8
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology